0216/26SCR018-12/R4RGB
Media Highlights
From the 2025 ASH Annual Meeting
5
Media Outlet Article / Coverage
Physician's Weekly Advancing Myeloma Care With New Therapies and Better
Triaging
Targeted Oncology Dr Hans Lee on the Game-Changing Myeloma Research From
ASH 2025
VJHemOnc ASH 2025 | Bispecific Antibodies in Myeloma:Top Trial Updates
from ASH 2025
Hans Lee, MD
SCRI
Media Outlet Article / Coverage
HealthTree Daratumumab + Lenalidomide vs Lenalidomide as Myeloma
Maintenance
Oncology Learning Network Daratumumab Added to Lenalidomide Maintenance Therapy
Following Transplant Improves Depth and Durability of MRD
Response for MM: AURIGA Study
Oncology News Central Out-of-Spec CAR-T May Still Offer Clinical Benefit in
Myeloma
Oncology News Central Investigational In Vivo CAR-T Potential Game Changer in
Multiple Myeloma
Mitul Gandhi, MD
SCRI at Virginia Cancer Specialists I The US Oncology Network
